Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/17/2007EP1844770A1 Tablets containing ornithine hydrochloride
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1844031A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/17/2007EP1844029A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
10/17/2007EP1844026A2 Morpholines as 5ht2c agonists
10/17/2007EP1844023A1 Quinazoline derivatives for the treatment and prevention of diabetes and obesity
10/17/2007EP1844021A1 Crystalline forms of rosuvastatin calcium salt
10/17/2007EP1844017A1 An amorphous and three crystalline forms of rimonabant hydrochloride
10/17/2007EP1844015A2 Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same
10/17/2007EP1843819A2 Methods of reducing body fat
10/17/2007EP1843769A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
10/17/2007EP1843760A1 Classes of compounds that interact with integrins
10/17/2007EP1648564B1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1420771B9 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1347745A4 Dietary composition containing conjugated linoleic acid and calcium for improved health
10/17/2007EP1313717B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007CN101056856A Method for preparing torsemide crystal with pure state
10/17/2007CN101056650A Stable formulations of insulinoptropic peptides
10/17/2007CN101056549A Packed beverage for lipid combustion promotion
10/17/2007CN101054571A In vitro proliferation method for pancreatic islet cell
10/17/2007CN101054415A Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein
10/17/2007CN101054364A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (ER) ligands and their use in the treatmentof inflammarory diseases
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053641A Baoyuan kidney-invigorating navel plaster
10/17/2007CN101053621A Traditional Chinese medicinal composition for treating obesity and its preparation method
10/17/2007CN101053598A Medicinal composition for treating cardio-cerebralvascular diseases and diabetes
10/17/2007CN101053592A Medicinal composition for treating impaired glucose tolerance and preparation method thereof
10/17/2007CN101053582A Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension
10/17/2007CN101053580A New medical application of traditional Chinese medicine privet and preparation method of its extraction
10/17/2007CN101053576A Medical application of fruit extraction of miracle fruit
10/17/2007CN101053438A Health care beverage
10/17/2007CN101053437A Organic germanium Ge-132 glossy ganoderma beverage and processing method
10/17/2007CN101053430A Ginseng leaf beverage and production process thereof
10/17/2007CN101053410A Health care product with weight-reducing function and its preparing method
10/17/2007CN101053407A Jujube medlar tea and producing technology thereof
10/17/2007CN101053406A Sterile medlar buds lowering blood lipoid beverage and food
10/17/2007CN101053404A Sterile medlar buds hypoglycemic beverage and food
10/17/2007CN101053403A Anti-senility anti-fatigue body-beautifying food and preparation method thereof
10/17/2007CN101053402A One set of pure food composition for repairing pancreas function and curing type II diabetes, and food therapeutic producing method
10/17/2007CN101053400A Oral liquid for male fat reduction
10/17/2007CN101053399A Matrimony vine cucumberskin
10/17/2007CN101053392A Soluble dietary fiber of konjak
10/17/2007CN101053386A 糯米保健粥 Glutinous rice porridge health
10/17/2007CN101053382A Sichun fritillary bulb wax gourd moon cake
10/17/2007CN101053359A Raspberry health care tea
10/17/2007CN101053350A Compound and processing technology of prolonging life tea having lower blood pressure, blood fat and hypoglycemic effects
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100343229C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha
10/17/2007CN100342913C Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/17/2007CN100342910C Insulin dripping pills and its preparation process
10/17/2007CN100342861C Red-yeast extract and preparation therefor
10/17/2007CN100342852C Dispersive glimepiride tablet and its prepn process
10/17/2007CN100342851C Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007CA2464068C .alpha.-form or .beta.-form crystal of (r)-2-(2-aminothiazol-4yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl)acetanilide
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2191478C Process for removing bile salts from a patient and alkylated compositions therefor
10/14/2007CA2582784A1 Methods and products for enhancing energy and nutrition in human beings
10/11/2007WO2007115058A2 Thiadiazolidinone inhibitors of ptpase
10/11/2007WO2007114945A2 Compositions and methods for enhancing the antioxidant status of animals
10/11/2007WO2007114855A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/11/2007WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007WO2007114499A1 Anti-fat-accumulation composition
10/11/2007WO2007114475A1 Cocrystal of c-glycoside derivative and l-proline
10/11/2007WO2007114128A1 Method for production of capsinoid-containing beverage/food
10/11/2007WO2007114124A1 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11β-HYDROXYSTEROID DEHYDROGENASE TYPE I
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113540A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle
10/11/2007WO2007113226A1 Organic compounds
10/11/2007WO2007112669A1 Dicyclooctane derivates, preparation processes and medical uses thereof
10/11/2007WO2007112566A1 Compositions and methods for treating atherosclerosis
10/11/2007WO2007017505A3 Treatment of metabolic diseases
10/11/2007WO2005097131A3 Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238767 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr)
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238762 Use of Antagonists of Hepatic Sympathetic Nerve Activity
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238757 Novel treatment
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1298